Westover Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Buy
11,842
+6,192
+110% +$715K 0.26% 77
2025
Q4
$595K Buy
+5,650
New +$530K 0.11% 132
2025
Q2
Sell
-5,593
Closed -$502K 237
2025
Q1
$502K Sell
5,593
-32,631
-85% -$3.05M 0.11% 141
2024
Q4
$3.8M Sell
38,224
-3,485
-8% -$359K 0.84% 26
2024
Q3
$4.74M Sell
41,709
-807
-2% -$95.9K 0.91% 24
2024
Q2
$5.26M Sell
42,516
-941
-2% -$121K 1.36% 17
2024
Q1
$5.73M Buy
43,457
+312
+0.7% +$38.5K 1.68% 14
2023
Q4
$4.7M Buy
43,145
+3,823
+10% +$397K 1.53% 17
2023
Q3
$4.05M Sell
39,322
-1,034
-3% -$111K 1.47% 17
2023
Q2
$4.66M Sell
40,356
-47
-0.1% -$5.34K 1.62% 12
2023
Q1
$4.3M Sell
40,403
-851
-2% -$91.9K 1.59% 15
2022
Q4
$4.58M Buy
41,254
+2,383
+6% +$244K 1.81% 13
2022
Q3
$3.35M Buy
38,871
+2,389
+7% +$213K 1.28% 25
2022
Q2
$3.33M Buy
36,482
+3,082
+9% +$273K 1.23% 27
2022
Q1
$2.74M Sell
33,400
-1,298
-4% -$102K 0.85% 32
2021
Q4
$2.66M Buy
34,698
+1,256
+4% +$100K 0.77% 37
2021
Q3
$2.51M Buy
33,442
+2,440
+8% +$186K 0.79% 35
2021
Q2
$2.41M Buy
31,002
+3,414
+12% +$254K 0.77% 38
2021
Q1
$2.03M Buy
27,588
+12,898
+88% +$951K 0.7% 44
2020
Q4
$1.15M Buy
14,690
+206
+1% +$15.8K 0.41% 62
2020
Q3
$1.15M Buy
14,484
+3,213
+29% +$252K 0.47% 57
2020
Q2
$832K Buy
11,271
+7,892
+234% +$594K 0.39% 69
2020
Q1
$248K Buy
+3,379
New +$266K 0.13% 100
2014
Q3
Sell
-4,463
Closed -$246K 93
2014
Q2
$246K Sell
4,463
-52
-1% -$2.84K 0.21% 80
2014
Q1
$245K Hold
4,515
0.23% 76
2013
Q4
$216K Hold
4,515
0.21% 75
2013
Q3
$205K Sell
4,515
-2,772
-38% -$127K 0.21% 70
2013
Q2
$323K Buy
+7,287
New +$325K 0.32% 58

Other funds holding MRK

Westover Capital Advisors's MRK Position: Q1 2026 in Review

Westover Capital Advisors increased its Merck (MRK) stake by 110% in Q1 2026, buying an estimated $715K and bringing the position to 11,842 shares worth $1.42M. The position accounts for 0.26% of the portfolio, ranked #77.

Westover Capital Advisors first reported a position in MRK in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.73M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Westover Capital Advisors held 11,842 shares of Merck worth $1.42M as of Q1 2026.
  • Westover Capital Advisors bought 6,192 Merck shares in Q1 2026, an estimated $715K.
  • Merck made up 0.26% of Westover Capital Advisors's portfolio in Q1 2026, its #77 holding.
  • Westover Capital Advisors first reported a position in Merck in Q2 2013 and has held it in 28 quarters since.
  • Westover Capital Advisors's Merck position peaked at $5.73M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Westover Capital Advisors's 13F filing for Q1 2026, filed 5 May 2026.